Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow(R) (EGF(R)) Mapping for use in Atrial Fibrillation Ablation

EGF Mapping system aims to improve patient outcomes by enabling precise and personalized ablation strategies MENLO PARK, Calif., Feb. 1, 2024 -- (Healthcare Sales & Marketing Network) -- Cortex announced today the initiation of its RESOLVE-AF trial (NC... Devices, Cardiology Cortex , RESOLVE-AF, Ablamap System, Ablacath Mapping Catheter, AFib
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news